Drug Shortage Report for SANDOZ FINASTERIDE

Last updated on 2025-04-02 History
Report ID 247627
Drug Identification Number 02322579
Brand name SANDOZ FINASTERIDE
Common or Proper name FINASTERIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FINASTERIDE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30FCT
ATC code G04CB
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-01-13
Estimated end date Unknown
Actual end date 2025-04-01
Shortage status Resolved
Updated date 2025-04-02
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-04-02 English Compare
v7 2025-04-01 French Compare
v6 2025-04-01 English Compare
v5 2025-04-01 French Compare
v4 2025-04-01 English Compare
v3 2025-04-01 English Compare
v2 2025-01-13 French Compare
v1 2025-01-13 English Compare

Showing 1 to 8 of 8